Effect of the supplementation of dietary rich phytoestrogens in altering the vitamin D levels in diet induced osteoporotic rat model

被引:9
作者
Chennaiah, S. [2 ]
Vijayalakshmi, V. [1 ]
Suresh, C. [1 ]
机构
[1] Natl Inst Nutr, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India
[2] Natl Inst Nutr, Div Endocrinol & Metab, Hyderabad 500007, Andhra Pradesh, India
关键词
Isoflavones; Osteoporosis; Vitamin D; Calcium; HORMONE REPLACEMENT THERAPY; BONE LOSS; OVARIECTOMIZED RATS; SOYBEAN ISOFLAVONE; ADULT WOMEN; GENISTEIN; OSTEOCLASTS; CALCIUM; 17-BETA-ESTRADIOL; EPIDEMIOLOGY;
D O I
10.1016/j.jsbmb.2010.03.070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plant-derived estrogen-like compounds such as isoflavones (IF) especially daidzein and genistein are said to be preserving the bone in the osteoporotic conditions. However, it is not known whether a combination of IF and calcium (Ca) supplementation attenuates losses in bone mass and prevents the loss of vitamin D (VD). The present study addresses the role of phytoestrogens (PE) and Ca supplementation in low Ca and low VD diet induced osteoporosis (OSP). Cowpea (CP) which has high amount of the IF was selected to study its effect on diet induced osteoporotic conditions. Female weanling WNIN rats (total of 68) were divided into five groups and fed for five weeks on semisynthetic diet with low Ca (0.15%) and low VD (0.1 IU/day/rat) in combination with low (10 mg/kg) or high (25 mg/kg) concentrations of PEs derived from CPIF. The study groups are: (I) normal Ca(0.47%) and normal VD (25IU/day/rat), (II) low Ca + low VD, (III) low Ca + low VD + low CPIF (10 mg/kg diet), (IV) low Ca + low VD + high CPIF (25 mg/kg diet) and (V) low Ca + low VD + 17-(-estradiol (3.2 mg/kg diet). After the development of OSP the group II was subgrouped into: (SG I) continued on low Ca + VD, (SG II) low CPIF, (SG III) high CPIF, (SG IV) 17-beta-estradiol and (SG V) normal Ca and VD. Serum 25-VD levels were in the range of 14-38 ng/ml in groups I, III, Wand V. where as the values were very low in the group II (5.8 ng/ml). These were partially reversed upon supplementation of CPIF. The results correlated with altered Ca levels, body weight, bone mineral density and content and other related biochemical parameters. The paper further explains the possibility of protective and therapeutic role of VD in the presence of CPIF in osteoporotic health manifestations. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:268 / 272
页数:5
相关论文
共 42 条
[1]  
Anderson JJB, 1998, P SOC EXP BIOL MED, V217, P345, DOI 10.3181/00379727-217-44243
[2]   Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis [J].
Arjmandi, BH ;
Alekel, L ;
Hollis, BW ;
Amin, D ;
StacewiczSapuntzakis, M ;
Guo, P ;
Kukreja, SC .
JOURNAL OF NUTRITION, 1996, 126 (01) :161-167
[3]   Soy isoflavones in the management of postmenopausal osteoporosis [J].
Atmaca, Aysegul ;
Kleerekoper, Michael ;
Bayraktar, Miyase ;
Kucuk, Omer .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (04) :748-757
[4]   Dietary phyto-oestrogens and bone health [J].
Branca, F .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2003, 62 (04) :877-887
[5]   Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study [J].
Brink, Elizabeth ;
Coxam, Veronique ;
Robins, Simon ;
Wahala, Kristiina ;
Cassidy, Aedin ;
Branca, Francesco .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 87 (03) :761-770
[6]   Review: developmental origins of osteoporotic fracture [J].
Cooper, C ;
Westlake, S ;
Harvey, N ;
Javaid, K ;
Dennison, E ;
Hanson, M .
OSTEOPOROSIS INTERNATIONAL, 2006, 17 (03) :337-347
[7]  
Cos P, 2003, PLANTA MED, V69, P589, DOI 10.1055/s-2003-41122
[8]   Epidemiology and outcomes of osteoporotic fractures [J].
Cummings, SR ;
Melton, LJ .
LANCET, 2002, 359 (9319) :1761-1767
[9]  
Davis SR, 1999, RECENT PROG HORM RES, V54, P185
[10]   Hormone replacement therapy: current controversies [J].
Davison, S ;
Davis, SR .
CLINICAL ENDOCRINOLOGY, 2003, 58 (03) :249-261